V

Verona Pharma plc
D

VRNA

38.790
USD
0.90
(2.38%)
مغلق
حجم التداول
22,975
الربح لكل سهم
-2
العائد الربحي
-
P/E
-19
حجم السوق
3,174,231,084
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALT
    -0.85500
    (-10.11%)
    7.60000 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    V
    VXRT
    -0.05030
    (-7.97%)
    0.58050 USD
    المزيد
الأخبار

العنوان: Verona Pharma plc

القطاع: Healthcare
الصناعة: Biotechnology
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.